Aug 2026
Engineered tumor cell membrane-coated manganese-amplified STING nanoagonist potentiates PD-L1 blockade immunotherapy in non-small cell lung cancer.
This biomimetic Mn2⁺-amplified STING nanoagonist provides a promising strategy for integrating innate immune activation with immune checkpoint blockade for enhanced NSCLC immunotherapy.
Ye Guo, Shi-Yun Feng, Kai-Zhong Wang et al.
· Colloids and Surfaces B: Bio... · 0 citations